Product
SRG-514
1 clinical trial
1 indication
Indication
Breast CancerClinical trial
A Phase 1 Study of SRG-514 Administered Intraoperatively to the Site of Tumor Resection of Patients Undergoing Breast-Conserving Cancer SurgeryStatus: Not yet recruiting, Estimated PCD: 2025-09-01